Related references
Note: Only part of the references are listed.Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting
Luka Mesin et al.
CELL (2020)
Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial
Sabrina H. Tsang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial
Aimee R. Kreimer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines
Sabrina H. Tsang et al.
VACCINE (2020)
Long-term HPV-specific immune response after one versus two and three doses of bivalent HPV vaccination in Dutch girls
Hella Pasmans et al.
VACCINE (2019)
Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial
Mahboobeh Safaeian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial
Mahboobeh Safaeian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Germinal center enhancement by extended antigen availability
Kimberly M. Cirelli et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials
Lone K. Petersen et al.
PAPILLOMAVIRUS RESEARCH (2017)
Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis
Daniel C. Beachler et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
How to assess the binding strength of antibodies elicited by vaccination against HIV and other viruses
P. J. Klasse
EXPERT REVIEW OF VACCINES (2016)
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
Rengaswamy Sankaranarayanan et al.
LANCET ONCOLOGY (2016)
A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects
Erin M. Scherer et al.
EBIOMEDICINE (2016)
Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica
Paula Gonzalez et al.
VACCINE (2015)
Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial
Mahboobeh Safaeian et al.
CANCER PREVENTION RESEARCH (2013)
Antibody Avidity in Humoral Immune Responses in Bangladeshi Children and Adults following Administration of an Oral Killed Cholera Vaccine
Mohammad Murshid Alam et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses Results from the Costa Rica vaccine trial
Mahboobeh Safaeian et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Direct Comparison of HPV16 Serological Assays Used to Define HPV-Naive Women in HPV Vaccine Trials
Mahboobeh Safaeian et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individuals
Joseph G. Dauner et al.
MOLECULAR AND CELLULAR PROBES (2012)
Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix®
Troy J. Kemp et al.
VACCINE (2012)
Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
Aimee R. Kreimer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
Surender Khurana et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Mechanisms that determine plasma cell lifespan and the duration of humoral immunity
Ian J. Amanna et al.
IMMUNOLOGICAL REVIEWS (2010)
Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine
Francis J. Dessy et al.
HUMAN VACCINES (2008)
Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women
Troy J. Kemp et al.
VACCINE (2008)
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica
Rolando Herrero et al.
VACCINE (2008)
Share Paper
